Genetics and Cytopathology Testing in Disease Diagnosis

Dear Colleagues,

Genetics and cytopathology testing play a critical role in diagnosing and treating various diseases. Genetic testing involves the analysis of an individual’s DNA to identify changes or mutations that may contribute to disease development. This type of testing is often used to diagnose genetic disorders such as cystic fibrosis, Huntington’s disease, and sickle cell anemia. On the other hand, cytopathology testing involves the examination of cells and tissues under a microscope to detect abnormalities that may indicate disease. This type of testing is commonly used to diagnose cancer, infections, and other conditions. By combining these two approaches, healthcare professionals can obtain a more comprehensive understanding of a patient’s condition, leading to more accurate diagnoses and better treatment outcomes. Genetics and cytopathology tests have enabled medical professionals to identify genetic mutations, assess disease progression, and predict treatment response, allowing for more personalized and precise healthcare. Moreover, these tests have also facilitated the development of novel therapies and targeted drugs, leading to better outcomes for patients and their families. This Special Issue entitled “Genetics and Cytopathology Testing in Disease Diagnosis” is intended to provide a platform for a wide range of reviews, research articles, communications, case reports and technical notes related to genetics and cytopathology studies in clinical diagnostics. We also welcome submissions that focus on a strong precision medicine component and are devoted to assay validation, novel variants in disease, as well as functional studies that impact variant evaluation for clinical pathogenicity associated with inherited diseases and cancer.

Dr. Marco Fabiani
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.